Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > Zebra Technologies > Benefiting from Bedside Specimen Labeling
 

Benefiting from Bedside Specimen Labeling

White Paper Published By: Zebra Technologies
Zebra Technologies
Published:  Sep 12, 2018
Type:  White Paper
Length:  8 pages

Labeling blood and other samples at the time they are collected improves patient safety and helps prevent a host of problems related to misidentification ó including many of the estimated 160,900 adverse events that occur in U.S. hospitals annually because of sample identification errors.1 There is a strong and growing body of evidence within medical literature that creating specimen identification labels on demand at the patient bedside with a mobile printer can significantly reduce errors. The Joint Commissionís National Patient Safety Goals (NPSG) for 2010 advocate the use of two patient-specific identifiers, such as name and birthdate, whenever taking blood or other samples from
a patient, and to label the sample collection container in the presence of the patient. Producing specimen labels at the patient bedside and encoding patient identification in a barcode satisfies both The Joint Commissionís NPSG and Health Insurance Portability and Accountability Act (HIPAA) requirements. This white paper explains the point-of care specimen labeling process, documents its benefits, outlines equipment and IT requirements, and provides tips for successful implementation.



Tags :